Related Experiment Video
Updated: Jun 19, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
Published on: July 22, 2025
PMX-CovEval: A Framework Including a Simulated Pharmacokinetic Database for Covariate Model Building Methods
Mélanie Karlsen1,2, Jérôme Azé1, Sandra Bringay1,3
1LIRMM, Laboratory of Computer Science, Robotics and Microelectronics in Montpellier, CNRS, Montpellier University, Montpellier, France.
Abstract:
The development of new methods for covariate model building (CMB) in population pharmacokinetics (popPK) highlights the need for a standardized evaluation framework for method benchmarking. This data paper introduces PMX-CovEval, a framework including a collection of datasets based on 127 distinct scenarios. These scenarios aim to reflect the diversity of models, available clinical studies, and covariates encountered in real-world applications, while remaining limited enough in number to encourage their practical use. To support the evaluation of standard CMB techniques available on PsN and Monolix, model files for NONMEM and Monolix are provided alongside the datasets. Additionally, empirical Bayes estimates (EBEs) from the true base models are included to facilitate the testing of EBE-based regression approaches. By offering pharmacokinetic (PK) datasets, model files, and EBEs in a unified resource, PMX-CovEval provides a standardized, reproducible framework for evaluation and systematic comparison of CMB strategies in popPK. Initial benchmarking results are also provided.
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Analysis of Population Pharmacokinetic Data

